1 | Testing | 2.86% | |
2 | Tissue | 2.86% | |
3 | Access | 2.86% | |
4 | Covid-19 | 2.86% | |
5 | Cutaneous | 2.86% | |
6 | Japan | 2.86% | |
7 | Randomized | 2.86% | |
8 | Connective | 2.86% | |
9 | Are | 2.86% | |
10 | Therapy | 2.86% | |
11 | Controlled | 2.86% | |
12 | Patients | 2.86% | |
13 | Penicillin | 2.86% | |
14 | Psychiatric | 2.86% | |
15 | Allergic | 2.86% | |
16 | Hydroxychloroquine | 2.86% | |
17 | Review | 2.86% | |
18 | Diseases | 2.86% | |
19 | Adverse | 2.86% | |
20 | Occupational | 2.86% | |
21 | Hospitalization | 2.86% | |
22 | Improve | 2.86% | |
23 | Literature | 2.86% | |
24 | Program | 2.86% | |
25 | Early | 2.86% | |
26 | Group | 2.86% | |
27 | Report | 2.86% | |
28 | Cases | 2.86% | |
29 | Three | 2.86% | |
30 | Effects | 2.86% | |
31 | Truly | 2.86% | |
32 | Stage | 2.86% | |
33 | Trial | 2.86% | |
34 | Leflunomide | 2.86% | |
35 | Can | 2.86% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|